Design and rationale of the WARRIOR ancillary study for coronary CT angiographic analysis

Balaji Tamarappoo1, Rafal Wolny2, Guadalupe Flores Tomasino3

  • 1Division of Cardiology, Department of Medicine, Mayo Clinic Arizona, Scottsdale, AZ.

American Heart Journal
|January 4, 2026
PubMed

Insights

Intensive medical therapy (IMT) may improve coronary plaque in women with INOCA. This study quantifies IMT’s impact on plaque composition and chest pain, offering new insights for non-obstructive coronary artery disease management.

Area of Science:

  • Cardiology
  • Medical Imaging
  • Translational Research

Background:

  • Over 50% of women with suspected ischemia have INOCA, a condition where plaque impact is not well understood.
  • Current treatments like statins and ACE inhibitors/ARBs show promise, but their effect on coronary plaque needs further characterization.

Purpose of the Study:

  • To evaluate the impact of intensive medical therapy (IMT) versus usual care (UC) on coronary plaque composition and chest pain in women with INOCA.
  • To hypothesize that IMT positively influences plaque characteristics, affecting flow reserve and clinical outcomes.
  • To utilize coronary CT angiography (CCTA) for detailed plaque and symptom analysis.

Main Methods:

  • The WARRIOR ancillary study will enroll 200 women with INOCA, randomized to IMT or UC.
  • Baseline and exit CCTA will be used to quantify changes in plaque and pericoronary adipose tissue (PCAT) characteristics.
  • AI-enabled quantification and PCAT density analysis will assess plaque inflammation and hemodynamic significance.

Main Results:

  • Changes in coronary plaque characteristics and their hemodynamic significance will be analyzed using AI-enabled CCTA quantification.
  • Plaque inflammatory characteristics will be assessed via PCAT density analysis.
  • Plaque burden, composition, and PCAT density will be correlated with angina scores (SAQ).
  • A machine learning risk score (MLRS) will be derived from CCTA variables to predict angina changes.

Conclusions:

  • This study is the first to quantify the effects of IMT versus UC on plaque composition in women with INOCA.
  • Findings will elucidate the impact of IMT on coronary plaque, potentially improving treatment strategies for INOCA patients.
Abstract

Related Concept Videos

Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
194
Imaging Studies for Cardiovascular System V: CT01:28

Imaging Studies for Cardiovascular System V: CT

Cardiac computed tomography (CT) scanning is an advanced cardiac imaging technique that utilizes CT technology, with or without intravenous (IV) contrast, to produce accurate cross-sectional virtual slices of specific areas of the heart, coronary circulation, and major blood vessels such as the aorta, pulmonary veins, and arteries. The computer processes these slices to generate three-dimensional images. Multidetector CT (MDCT) is a rapid form of CT scanning that captures multiple slices...
252
Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT01:25

Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT

Calcium-Scoring CT ScanA calcium-scoring CT scan, also known as coronary artery calcium (CAC) scan, detects calcium deposits in the coronary arteries. This test assesses the risk of coronary artery disease (CAD), which can lead to cardiovascular events such as angina, heart failure, and sudden cardiac arrest.A calcium-scoring CT scan is generally recommended for individuals at intermediate risk of CAD without symptoms. It includes:Men aged 40-75 and women aged 50-75: Especially those with a...
362